252 related articles for article (PubMed ID: 17696930)
21. Suppression of DHEA sulfotransferase (Sult2A1) during the acute-phase response.
Kim MS; Shigenaga J; Moser A; Grunfeld C; Feingold KR
Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E731-8. PubMed ID: 15198932
[TBL] [Abstract][Full Text] [Related]
22. On the mechanism of bile acid inhibition of rat sterol 12alpha-hydroxylase gene (CYP8B1) transcription: roles of alpha-fetoprotein transcription factor and hepatocyte nuclear factor 4alpha.
Yang Y; Zhang M; Eggertsen G; Chiang JY
Biochim Biophys Acta; 2002 Jun; 1583(1):63-73. PubMed ID: 12069850
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-210 Promotes Bile Acid-Induced Cholestatic Liver Injury by Targeting Mixed-Lineage Leukemia-4 Methyltransferase in Mice.
Kim YC; Jung H; Seok S; Zhang Y; Ma J; Li T; Kemper B; Kemper JK
Hepatology; 2020 Jun; 71(6):2118-2134. PubMed ID: 31549733
[TBL] [Abstract][Full Text] [Related]
24. Fxr(-/-) mice adapt to biliary obstruction by enhanced phase I detoxification and renal elimination of bile acids.
Marschall HU; Wagner M; Bodin K; Zollner G; Fickert P; Gumhold J; Silbert D; Fuchsbichler A; Sjövall J; Trauner M
J Lipid Res; 2006 Mar; 47(3):582-92. PubMed ID: 16327028
[TBL] [Abstract][Full Text] [Related]
25. Changes of organic anion transporter MRP4 and related nuclear receptors in human obstructive cholestasis.
Chai J; Luo D; Wu X; Wang H; He Y; Li Q; Zhang Y; Chen L; Peng ZH; Xiao T; Wang R; Chen W
J Gastrointest Surg; 2011 Jun; 15(6):996-1004. PubMed ID: 21359593
[TBL] [Abstract][Full Text] [Related]
26. Analysis of bile acid-induced regulation of FXR target genes in human liver slices.
Jung D; Elferink MG; Stellaard F; Groothuis GM
Liver Int; 2007 Feb; 27(1):137-44. PubMed ID: 17241392
[TBL] [Abstract][Full Text] [Related]
27. Impact of parenteral nutrition versus fasting on hepatic bile acid production and transport in a rabbit model of prolonged critical illness.
Vanwijngaerden YM; Langouche L; Derde S; Liddle C; Coulter S; van den Berghe G; Mesotten D
Shock; 2014 Jan; 41(1):48-54. PubMed ID: 24089008
[TBL] [Abstract][Full Text] [Related]
28. Multidrug resistance-associated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the rat.
Denk GU; Soroka CJ; Takeyama Y; Chen WS; Schuetz JD; Boyer JL
J Hepatol; 2004 Apr; 40(4):585-91. PubMed ID: 15030973
[TBL] [Abstract][Full Text] [Related]
29. Sustained upregulation of sodium taurocholate cotransporting polypeptide and bile salt export pump and downregulation of cholesterol 7α-hydroxylase in the liver of patients with end-stage primary biliary cirrhosis.
Takeyama Y; Kanegae K; Inomata S; Takata K; Tanaka T; Ueda S; Yokoyama K; Morihara D; Nishizawa S; Anan A; Irie M; Iwata K; Shakado S; Sohda T; Sakisaka S
Med Mol Morphol; 2010 Sep; 43(3):134-8. PubMed ID: 20857261
[TBL] [Abstract][Full Text] [Related]
30. Fibrates and cholestasis.
Ghonem NS; Assis DN; Boyer JL
Hepatology; 2015 Aug; 62(2):635-43. PubMed ID: 25678132
[TBL] [Abstract][Full Text] [Related]
31. Interactions between hepatic Mrp4 and Sult2a as revealed by the constitutive androstane receptor and Mrp4 knockout mice.
Assem M; Schuetz EG; Leggas M; Sun D; Yasuda K; Reid G; Zelcer N; Adachi M; Strom S; Evans RM; Moore DD; Borst P; Schuetz JD
J Biol Chem; 2004 May; 279(21):22250-7. PubMed ID: 15004017
[TBL] [Abstract][Full Text] [Related]
32. Bile acid detoxifying enzymes limit susceptibility to liver fibrosis in female SHRSP5/Dmcr rats fed with a high-fat-cholesterol diet.
Yetti H; Naito H; Yuan Y; Jia X; Hayashi Y; Tamada H; Kitamori K; Ikeda K; Yamori Y; Nakajima T
PLoS One; 2018; 13(2):e0192863. PubMed ID: 29438418
[TBL] [Abstract][Full Text] [Related]
33. Cholestasis-induced bile acid elevates estrogen level via farnesoid X receptor-mediated suppression of the estrogen sulfotransferase SULT1E1.
Liu X; Xue R; Yang C; Gu J; Chen S; Zhang S
J Biol Chem; 2018 Aug; 293(33):12759-12769. PubMed ID: 29929982
[TBL] [Abstract][Full Text] [Related]
34. Cytokine-independent repression of rodent Ntcp in obstructive cholestasis.
Geier A; Zollner G; Dietrich CG; Wagner M; Fickert P; Denk H; van Rooijen N; Matern S; Gartung C; Trauner M
Hepatology; 2005 Mar; 41(3):470-7. PubMed ID: 15723437
[TBL] [Abstract][Full Text] [Related]
35. BRD4 inhibition and FXR activation, individually beneficial in cholestasis, are antagonistic in combination.
Jung H; Chen J; Hu X; Sun H; Wu SY; Chiang CM; Kemper B; Chen LF; Kemper JK
JCI Insight; 2020 Dec; 6(1):. PubMed ID: 33290278
[TBL] [Abstract][Full Text] [Related]
36. Involvement of corepressor complex subunit GPS2 in transcriptional pathways governing human bile acid biosynthesis.
Sanyal S; Båvner A; Haroniti A; Nilsson LM; Lundåsen T; Rehnmark S; Witt MR; Einarsson C; Talianidis I; Gustafsson JA; Treuter E
Proc Natl Acad Sci U S A; 2007 Oct; 104(40):15665-70. PubMed ID: 17895379
[TBL] [Abstract][Full Text] [Related]
37. Protective effects of SRT1720 via the HNF1α/FXR signalling pathway and anti-inflammatory mechanisms in mice with estrogen-induced cholestatic liver injury.
Yu L; Liu X; Li X; Yuan Z; Yang H; Zhang L; Jiang Z
Toxicol Lett; 2016 Dec; 264():1-11. PubMed ID: 27818225
[TBL] [Abstract][Full Text] [Related]
38. Farnesoid X receptor-induced lysine-specific histone demethylase reduces hepatic bile acid levels and protects the liver against bile acid toxicity.
Kim YC; Fang S; Byun S; Seok S; Kemper B; Kemper JK
Hepatology; 2015 Jul; 62(1):220-31. PubMed ID: 25545350
[TBL] [Abstract][Full Text] [Related]
39. Benefit of farnesoid X receptor inhibition in obstructive cholestasis.
Stedman C; Liddle C; Coulter S; Sonoda J; Alvarez JG; Evans RM; Downes M
Proc Natl Acad Sci U S A; 2006 Jul; 103(30):11323-8. PubMed ID: 16844773
[TBL] [Abstract][Full Text] [Related]
40. Loss of orphan receptor small heterodimer partner sensitizes mice to liver injury from obstructive cholestasis.
Park YJ; Qatanani M; Chua SS; LaRey JL; Johnson SA; Watanabe M; Moore DD; Lee YK
Hepatology; 2008 May; 47(5):1578-86. PubMed ID: 18393320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
